1. Home
  2. IMAB vs STEM Comparison

IMAB vs STEM Comparison

Compare IMAB & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • STEM
  • Stock Information
  • Founded
  • IMAB 2014
  • STEM 2009
  • Country
  • IMAB United States
  • STEM United States
  • Employees
  • IMAB N/A
  • STEM N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • STEM Computer Software: Prepackaged Software
  • Sector
  • IMAB Health Care
  • STEM Technology
  • Exchange
  • IMAB Nasdaq
  • STEM Nasdaq
  • Market Cap
  • IMAB 83.8M
  • STEM 74.7M
  • IPO Year
  • IMAB 2020
  • STEM N/A
  • Fundamental
  • Price
  • IMAB $1.39
  • STEM $0.41
  • Analyst Decision
  • IMAB Strong Buy
  • STEM Hold
  • Analyst Count
  • IMAB 3
  • STEM 12
  • Target Price
  • IMAB $8.00
  • STEM $2.71
  • AVG Volume (30 Days)
  • IMAB 378.4K
  • STEM 6.0M
  • Earning Date
  • IMAB 08-28-2024
  • STEM 10-30-2024
  • Dividend Yield
  • IMAB N/A
  • STEM N/A
  • EPS Growth
  • IMAB N/A
  • STEM N/A
  • EPS
  • IMAB N/A
  • STEM N/A
  • Revenue
  • IMAB $3,492,091.00
  • STEM $360,632,000.00
  • Revenue This Year
  • IMAB N/A
  • STEM N/A
  • Revenue Next Year
  • IMAB N/A
  • STEM $131.69
  • P/E Ratio
  • IMAB N/A
  • STEM N/A
  • Revenue Growth
  • IMAB N/A
  • STEM N/A
  • 52 Week Low
  • IMAB $0.99
  • STEM $0.30
  • 52 Week High
  • IMAB $2.54
  • STEM $4.30
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 63.28
  • STEM 46.70
  • Support Level
  • IMAB $1.02
  • STEM $0.31
  • Resistance Level
  • IMAB $1.50
  • STEM $0.50
  • Average True Range (ATR)
  • IMAB 0.10
  • STEM 0.05
  • MACD
  • IMAB 0.04
  • STEM 0.02
  • Stochastic Oscillator
  • IMAB 77.08
  • STEM 57.81

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on innovative technology services that transform the way energy is distributed and consumed.

Share on Social Networks: